Zenas BioPharma, Inc. (ZBIO) annual balance sheet — 4-year assets, liabilities & equity history
| Total Current Assets | 730.16M | 351.17M | 355.92M | 59.8M | 68.44M |
| Cash & Short-Term Investments | 717.21M | 343.19M | 350.77M | 56.86M | 67.21M |
| Cash Only | 500.22M | 110.64M | 319.74M | 56.86M | 67.21M |
| Short-Term Investments | 216.98M | 232.55M | 31.02M | 0 | 0 |
| Accounts Receivable | 1.1M | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - |
| Other Current Assets | 11.86M | 7.98M | 5.16M | 2.95M | 1.24M |
| Total Non-Current Assets | 17.52M | 32.47M | 14.04M | 8.38M | 6.13M |
| Property, Plant & Equipment | 1.12M | 1.39M | 1.19M | 1.01M | 1.8M |
| Fixed Asset Turnover | 0.00x | 7.20x | 4.21x | 49.31x | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 30.94M | 17.27M | 0 | 0 | 0 |
| Other Non-Current Assets | 15.06M | 13.81M | 12.86M | 7.36M | 4.33M |
| Total Assets | 747.68M | 383.64M | 369.97M | 68.18M | 74.58M |
| Asset Turnover | 0.00x | 0.03x | 0.01x | 0.73x | - |
| Asset Growth % | 154.11% | 3.7% | 442.63% | -8.58% | - |
| Total Current Liabilities | 61.16M | 62.65M | 57.29M | 23.26M | 25.97M |
| Accounts Payable | 8.94M | 7.11M | 17.14M | 5.4M | 5.82M |
| Days Payables Outstanding | 57.81 | - | 44.95 | - | 34.41 |
| Short-Term Debt | 1.04M | 1.11M | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 45.44M | 54.3M | 8.31M | 5.12M | 4.33M |
| Current Ratio | 11.94x | 5.61x | 6.21x | 2.57x | 2.64x |
| Quick Ratio | 11.94x | 5.61x | 6.21x | 2.57x | 2.64x |
| Cash Conversion Cycle | - | - | - | - | - |
| Total Non-Current Liabilities | 350.69M | 78.85M | 218K | 270.64M | 240.9M |
| Long-Term Debt | 350.62M | 78.64M | 0 | 20.3M | 0 |
| Capital Lease Obligations | 683K | 211K | 218K | 257K | 812K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 250.09M | 240.09M |
| Total Liabilities | 411.85M | 141.5M | 57.51M | 293.9M | 266.87M |
| Total Debt | 351.73M | 79.96M | 1M | 21.11M | 1.53M |
| Net Debt | -148.5M | -30.68M | -318.74M | -35.74M | -65.68M |
| Debt / Equity | 1.05x | 0.33x | 0.00x | - | - |
| Debt / EBITDA | -0.83x | - | - | - | - |
| Net Debt / EBITDA | 0.35x | - | - | - | - |
| Interest Coverage | -62.50x | -50.56x | - | - | - |
| Total Equity | 335.83M | 242.14M | 312.46M | -225.72M | -192.29M |
| Equity Growth % | -0.74% | -22.5% | 238.43% | -17.39% | - |
| Book Value per Share | 6.04 | 5.41 | 7.48 | -5.89 | -5.02 |
| Total Shareholders' Equity | 335.83M | 242.14M | 312.46M | -225.72M | -192.29M |
| Common Stock | 6K | 5K | 4K | 0 | 0 |
| Retained Earnings | -846.12M | -765.13M | -387.39M | -230.4M | -193.28M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -377K | -64K | 194K | 37K | -41K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying ZBIO stock.
As of 2025, Zenas BioPharma, Inc. (ZBIO) had total assets of $383.6M including $351.2M in current assets.
Zenas BioPharma, Inc. (ZBIO) carries total debt of $80.0M, offset by $343.2M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Zenas BioPharma, Inc. (ZBIO) has total shareholders' equity (book value) of $242.1M ($5.41 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Zenas BioPharma, Inc. (ZBIO) reported a current ratio of 5.61x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.